In December 2020, UNAIDS released a new set of ambitious targets calling for 95% of all people living with HIV to know their HIV status, 95% of all people with diagnosed HIV infection to receive sustained antiretroviral therapy, and 95% of all people receiving antiretroviral therapy to have viral suppression by 2025. In 2021, an estimated 38 million people were living with human immunodeficiency virus (HIV) globally, with over two-thirds living in African regions. In South Africa, ~20% of South African adults are living with HIV. Ahead of World Aids Day next week, we speak to the CEO of SANAC. Dr. Xulu is a seasoned public health practitioner with a special focus on HIV and TB response. She was with the Right to Care (RTC) Group for over 15 years where she served in various capacities ranging from being Manager of the HIV Expert Treatment Programme to Executive Director of the Group in 2007 and served on the RTC board until March 2020. She previously was Chief of Party of EQUIP, the first African-led USAID funded international consortium of HIV implementing partners which was established to rapidly scale up innovative HIV treatment and prevention solutions towards meeting the UNAIDS 90-90-90 goals in more than 10 PEPFAR supported countries. She is a medical doctor who graduated with an MBChB from the University of KwaZulu Natal. She further obtained two diplomas from The Colleges of Medicine of South Africa; one in Obstetrics and another in HIV Management. In 2008, she completed her Master’s Degree in Public Health (Health Management and Health Policy) from the University of the Witwatersrand. She is a 2010 Yale University World Fellow and she is also a Certified Director with the Institute of Directors of South Africa.